Point of Care & Rapid Diagnostics Market projected to Reach USD 72.0 billion by 2027

1
(No Transcript)
2
Point of Care Rapid Diagnostics Market
MARKET OPPORTUNITY OVER NEXT 5 YEARS
by Product
KEY MARKET PLAYERS
CAGR of
2022 2027

• Abbott Laboratories (US)
• Siemens Healthineers AG (Germany)
• Quidel Corporation (US)
• F. Hoffman-La Roche Ltd. (Switzerland)
• Danaher Corporation (US)
• Becton
• Dickinson and Company (US)

CAGR

• Glucose
• Infectious Disease(HIV, Hepatitis C)
• Pregnancy Test

By end user
North America Europe Asia Pacific Rest of the
World

• Pharmacy
• Hospital
• Home

3
The Global Point of Care Rapid Diagnostics
Market is expected to reach USD 72.0 billion by
2027 from an estimated USD 43.2 billion in 2022,
at a CAGR of 10.8 from 2022 to 2027. The growth
of the global Point of Care diagnostics market
can be attributed to factors such as increasing
prevalence of respiratory diseases (such as
COVID-19 and influenza) across the globe, and
improved access to point-of-care devices through
online platforms are some of the other key
factors likely to drive the long-term growth of
the point-of-care diagnostics market. Download
PDF Brochure https//www.marketsandmarkets.com/p
dfdownloadNew.asp?id106829185 Key
Players Abbott Laboratories (US), Siemens
Healthineers AG (Germany), Quidel Corporation
(US), F. Hoffman-La Roche Ltd. (Switzerland),
Danaher Corporation (US), Becton, Dickinson and
Company (US), Chembio Diagnostics (US), EKF
Diagnostics (UK), Trinity Biotech plc (Ireland),
Instrumentation Laboratory (a Werfen Company)
(US), Nova Biomedical (US), PTS Diagnostics (US),
Sekisui Diagnostics (US), Thermo Fisher
Scientific (US), and bioMérieux S.A. (France)
4
Rapid Diagnostics Market Dynamics Driver High
prevalence of infectious diseases POC tests can
greatly improve the management of infectious
diseases, especially in developing countries
where access to timely medical care is a
challenge and the healthcare infrastructure is
antiquated and sparse. According to UNAIDS,
around 20.6 million people were living with HIV
in East and Southern Africa in 2018. In 2019,
20,000 new HIV cases were registered in the
Middle East and North Africa (Source UNAIDS Data
2020). In the Asia Pacific, an estimated 5.8
million people were suffering from HIV in 2019,
led by India and China. According to UNAIDS, in
2019, approximately 2.1 million people in India
were infected with HIV. The high prevalence of
HIV is likely to boost the demand for
point-of-care diagnostics, further accelerating
the treatment of HIV infection. Opportunity
Emerging markets Emerging markets such as China,
India, Brazil, and Mexico are expected to offer
significant growth opportunities for players
operating in the POC diagnostics market. This is
primarily due to the high and growing prevalence
of infectious and lifestyle diseases in these
countries. Globally, China has the highest number
of diabetes patients, with around 114 million
people suffering from diabetes in the country in
2017. Similarly, in emerging countries such as
Brazil and India, the prevalence of diabetes,
CVDs, and HIV/AIDS is very high. In India, heart
diseases accounted for 28 of all deaths in 2016,
or 2.8 million people this is projected to
reach 4.8 million by 2020 (Source CCDC,
India).
5

• Listed below are important statistics related to
  major infectious diseases in developing
  countries
• According to the WHO, India has the highest
  tuberculosis burden, with an estimated incidence
  of 2.64 million cases in 2020.
• In 2019, around 4.3 million new tuberculosis
  cases were reported in Southeast Asia, and
  632,000 people died due to TB infections in this
  region (Source WHO).
• According to the National Influenza Policy 2017,
  around 10,000 deaths and 40,000 hospitalizations
  are caused due to influenza in South Africa each
  year.
• According to the WHO, 1.2 million people in
  Southeast Asia suffer from malaria, with India
  alone accounting for 76 of the total alaria
  cases.
• During 20142016, West Africa reported the
  largest Ebola epidemic in the region in two and
  a half years, the outbreak resulted in more than
  28,600 cases and 11,325 deaths.
• In 2020, an estimated 15,898 people in Brazil
  were at risk of Zika virus infections, down from
  over 30,000 cases reported a year earlier.
• Get Sample Pages
• https//www.marketsandmarkets.com/requestsampleNew
  .asp?id106829185

6
About MarketsandMarkets MarketsandMarkets
provides quantified B2B research on 30,000 high
growth niche opportunities/threats which will
impact 70 to 80 of worldwide companies'
revenues. Currently servicing 7500 customers
worldwide including 80 of global Fortune 1000
companies as clients. Almost 75,000 top officers
across eight industries worldwide approach
MarketsandMarkets for their painpoints around
revenues decisions. Our 850 fulltime analyst and
SMEs at MarketsandMarkets are tracking global
high growth markets following the "Growth
Engagement Model GEM". The GEM aims at
proactive collaboration with the clients to
identify new opportunities, identify most
important customers, write "Attack, avoid and
defend" strategies, identify sources of
incremental revenues for both the company and its
competitors. MarketsandMarkets now coming up
with 1,500 MicroQuadrants (Positioning top
players across leaders, emerging companies,
innovators, strategic players) annually in high
growth emerging segments. MarketsandMarkets is
determined to benefit more than 10,000 companies
this year for their revenue planning and help
them take their innovations/disruptions early to
the market by providing them research ahead of
the curve. MarketsandMarkets's flagship
competitive intelligence and market research
platform, "Knowledge Store" connects over 200,000
markets and entire value chains for deeper
understanding of the unmet insights along with
market sizing and forecasts of niche markets.
7
Contact Mr. Aashish Mehra MarketsandMarkets
INC. 630 Dundee Road Suite 430 Northbrook, IL
60062 USA 1-888-600-6441 Email
sales_at_marketsandmarkets.com View Full Report -
https//www.marketsandmarkets.com/Market-Reports/p
oint-of-care-diagnostic-market-106829185.html